Bausch Health Companies (BHC) Cash from Operations (2009 - 2026)
Bausch Health Companies (BHC) reported Cash from Operations of 230000000.0 for Q1 2026, up 9.0% on a YoY basis from 211000000.0 in Q1 2025, and down 53.54% sequentially from 495000000.0 in Q4 2025.
Bausch Health Companies (BHC) Cash from Operations (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Cash from Operations data on file, last reported at 230000000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 9.0% year-over-year to 230000000.0; the trailing twelve-month figure through Mar 2026 stood at 1419000000.0 (down 11.15% YoY), and the FY2025 full-year result was 1400000000.0, down 12.34% from the prior year.
- Cash from Operations slipped to 230000000.0 in Q1 2026, from 495000000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 601000000.0 in Q4 2024 to a low of 1263000000.0 in Q3 2022.
- A 5-year average of 207705882.35 and a median of 282000000.0 in 2023 frame the typical range for Cash from Operations.
- Peak annual rise in Cash from Operations reached 1879.17% in 2022, while the deepest fall reached 323.94% in 2022.
- Tracing BHC's Cash from Operations over 5 years: stood at 475000000.0 in 2022, then decreased by 17.89% to 390000000.0 in 2023, then jumped by 54.1% to 601000000.0 in 2024, then dropped by 17.64% to 495000000.0 in 2025, then slumped by 53.54% to 230000000.0 in 2026.
- Business Quant data shows BHC's Cash from Operations at 230000000.0 in Q1 2026, 495000000.0 in Q4 2025, and 405000000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | 230.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 230.00 Mn |
| Mar 31, 2026 | 230.00 Mn |
| Dec 31, 2025 | 495.00 Mn |
| Dec 31, 2025 | 495.00 Mn |
| Sep 30, 2025 | 405.00 Mn |
| Sep 30, 2025 | 405.00 Mn |
| Jun 30, 2025 | 289.00 Mn |
| Jun 30, 2025 | 289.00 Mn |
| Mar 31, 2025 | 211.00 Mn |
| Mar 31, 2025 | 211.00 Mn |
| Dec 31, 2024 | 601.00 Mn |
| Dec 31, 2024 | 601.00 Mn |
| Sep 30, 2024 | 405.00 Mn |
| Sep 30, 2024 | 405.00 Mn |
| Jun 30, 2024 | 380.00 Mn |
| Jun 30, 2024 | 380.00 Mn |
| Mar 31, 2024 | 211.00 Mn |
| Mar 31, 2024 | 211.00 Mn |
| Dec 31, 2023 | 390.00 Mn |
| Dec 31, 2023 | 390.00 Mn |